gip/glp-1 tirzepatide GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 GLP-1 & GIP Weight Loss

Moreover, drugs with greater efficacy are being developed by combining two or three of GLP-1 and GIP or glucagon or amylin

These meals pack more protein into smaller portions, so you can eat less without missing out on nourishment

If the request meets pre-set criteria, the payer can send an immediate auto-approval response

Large employer health benefit plans increasingly include GLP-1 medications in formularies, though typically with prior authorization requirements and step therapy protocols

A 2024 meta-analysis (Sattar et al., Lancet Diabetes Endocrinol) found that switching from semaglutide to tirzepatide produced an additional 4.2 kg mean weight loss over 40 weeks, even when semaglutide had been titrated to maximum dose